Literature DB >> 33646465

An inquest into regulatory mechanism of caveolin by ischemic preconditioning against orchidectomy-challenged rat heart.

Ritesh Kumar Srivastav1,2, Tarique Mahmood Ansari3, Mahesh Prasad1, Vishal Kumar Vishwakarma4, Prabhat Kumar Upadhyay5, Farogh Ahsan2, Arshiya Shamim2.   

Abstract

Lower level of testosterone in men is related to major risks of cardiovascular diseases. This risk may increase due to the opening of mitochondrial permeability transition pore (mPTP). The mPTP is also regulated by ischemic preconditioning (IPC) and a membrane protein known as caveolin. The cardioprotective effect of IPC is the most effective methodologies used in testosterone deficiency. Daidzein (DDZ) a caveolin inhibitor shows cardioprotective action. The experiment has been designed to evaluate the pretreated DDZ effect in IPC-mediated cardioprotective action in orchidectomy (OCZ)-challenged rat heart. The experiment was designed on male Wistar rats with/without OCZ. The level of testosterone is decreased by OCZ which reduces general body growth. Isolated heart from normal and OCZ rat was tied up on Langendorff's perfused apparatus and followed by ischemic reperfusion (IR) and IPC cycle. To investigate the cardioprotective effect of DDZ in heart with testosterone deficiency, a total of nine groups, each consisting of six rats (n = 6) were as follows: Sham, IR, IPC, IPC + OCZ, IPC + DDZ, IPC + OCZ + DDZ, IPC + sodium nitrite, IPC + OCZ + sodium nitrite, IPC + OCZ + DDZ + sodium nitrite. Hemodynamic parameters, cellular injury (infarct size, LDH, CKMB and cardiac troponin-T), oxidative stress, mitochondrial function, integrity and immunoblot analysis were assessed for each group. The experimental data showed that DDZ potentiated IPC-mediated increase in the heart rate, left ventricular diastolic pressure, coronary flow; + dp/dtmax, and - dp/dtmax. The pretreated DDZ decreases the action of LDH and CKMB, myocyte size, cardiac collagen content, infarct size and ventricular fibrillation and attenuation in oxidative stress and mitochondrial dysfunction in OCZ-challenged rat heart in all sets of experiments. Sodium nitrite, a producer of nitric oxide (NO), enhanced potentiating effects of DDZ on IPC-mediated cardioprotection in OCZ-challenged rats. These observations show that the downregulation of caveolin through impaired opening of mPTP during reperfusion and caveolin might be a potential adjuvant to IPC against cardiac injury in OCZ-challenged rats.

Entities:  

Keywords:  Caveolin; Ischemic preconditioning; Mitochondria; Oxidative stress; Testosterone

Mesh:

Substances:

Year:  2021        PMID: 33646465     DOI: 10.1007/s11010-021-04109-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.

Authors:  D Stokoe; L R Stephens; T Copeland; P R Gaffney; C B Reese; G F Painter; A B Holmes; F McCormick; P T Hawkins
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

Review 2.  Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?

Authors:  P Ferdinandy; Z Szilvassy; G F Baxter
Journal:  Trends Pharmacol Sci       Date:  1998-06       Impact factor: 14.819

3.  Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; P L Sharma
Journal:  Mol Cell Biochem       Date:  2010-05-30       Impact factor: 3.396

4.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

Review 5.  Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

Authors:  Peter Ferdinandy; Rainer Schulz; Gary F Baxter
Journal:  Pharmacol Rev       Date:  2007-11-29       Impact factor: 25.468

6.  Preconditioning does not prevent postischemic dysfunction in aging heart.

Authors:  P Abete; N Ferrara; A Cioppa; P Ferrara; S Bianco; C Calabrese; F Cacciatore; G Longobardi; F Rengo
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

7.  Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart.

Authors:  Kavita Garg; Harlokesh N Yadav; Manjeet Singh; P L Sharma
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

8.  Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Preeti Ajmani; Harlokesh N Yadav; Manjeet Singh; Pyare L Sharma
Journal:  BMC Cardiovasc Disord       Date:  2011-07-12       Impact factor: 2.298

9.  Caveolin induces cardioprotection through epigenetic regulation.

Authors:  Manika Das; Somak Das; Istvan Lekli; Dipak K Das
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 10.  Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review.

Authors:  Saga Johansson; Annika Rosengren; Kate Young; Em Jennings
Journal:  BMC Cardiovasc Disord       Date:  2017-02-07       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.